The development of liver cirrhosis in a patient taking long-term weight loss supplements
https://doi.org/10.31146/1682-8658-ecg-216-8-176-183
Abstract
Dietary supplements are often self-administered by patients for weight loss. However, the hepatotoxicity of such supplements remains underestimated. Liver damage is diverse: from asymptomatic reversible course to lethal fulminant hepatitis. In the case of a long unrecognized course and prolonged use of dietary supplements, irreversible structural and functional damage to the organ occurs. We present a retrospective analysis of the case histories of a patient with liver cirrhosis, who has a long history of using dietary supplements of Thai and Chinese origin, hellebore extract, during 5 years of follow-up. Despite the discontinuation of weight loss drugs, regular complex therapy, the patient has a steady progressive course of the disease. Obese patients with an increased risk of liver damage require a dynamic assessment of liver function, not only when prescribing drugs, but also when using various dietary supplements.
About the Authors
T. V. Goma
Irkutsk State Medical University Health Ministry of Russian Federation
Russian Federation
Russian Federation
N. M. Kozlova
Irkutsk State Medical University Health Ministry of Russian Federation
Russian Federation
Russian Federation
K. S. Boldyreva
Irkutsk State Medical University Health Ministry of Russian Federation
Russian Federation
Russian Federation
References
1. Polunina T. E. Drug-induced liver injury. RMJ. Medical Review. 2018;7(I):7-12. (In Russ.)@@ Полунина Т. Е. Лекарственные повреждения печени. РМЖ. Медицинское обозрение. 2018;7(I):7-12.
2. Ivashkin V.T., Baranovsky A. Yu., Raikhelson K. L. et al. Drug-Induced Liver Injuries (Clinical Guidelines for Physicians).Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2019;29(1):101-131. (In Russ.) doi: 10.22416/1382-4376-2019-29-1-101-131.@@ Ивашкин В. Т., Барановский А. Ю., Райхельсон К. Л. и др. Лекарственные поражения печени (клинические рекомендации для врачей). Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2019;29(1):101-131. doi: 10.22416/1382-4376-2019-29-1-101-131.
3. Lazebnik L. B., Golovanova E. V., Hlynova O. V. et al. Medicinal liver damage in adults. Experimental and Clinical Gastroenterology. 2020;174(2):29-54. (In Russ.) doi: 10.31146/1682-8658-ecg-174-2-29-54.@@ Лазебник Л. Б., Голованова Е. В., Хлынова О. В. и др. Лекарственные поражения печени (ЛПП) у взрослых. Экспериментальная и клиническая гастроэнтерология. 2020;174(2):29-54. doi: 10.31146/1682-8658-ecg-174-2-29-54.
4. Korenskaya E.G., Paramonova O. V. Drug-induced liver injury is one of the important problems in the comorbid patient. Consilium Medicum. 2019;21(8):78-83. (In Russ.) doi: 10.26442/20751753.2019.8.190355.@@ Коренская Е. Г., Парамонова О. В. Лекарственные поражения печени - одна из важных проблем у коморбидного пациента. Consilium Medicum. 2019;21(8):78-83. doi: 10.26442/20751753.2019.8.190355.
5. Maksimov M.L., Simakova S. A. A review of cases of development of acute hepatic insufficiency due to the intake of biologically active additives. Safety and Risk of Pharmacotherapy. 2018;6(2):68-77. (In Russ.) doi: 10.30895/2312-7821-2018-6-2-68-77.@@ Максимов М. Л., Симакова С. А. Обзор случаев развития острой печеночной недостаточности вследствие приема биологически активных добавок. Безопасность и риск фармакотерапии. 2018;6(2):68-77. doi: 10.30895/2312-7821-2018-6-2-68-77.
6. Woo SM, Davis WD, Aggarwal S, et al. Herbal and dietary supplement induced liver injury: Highlights from the recent literature. World J Hepatol. 2021;13(9):1019-1041. doi: 10.4254/wjh.v13.i9.1019.
7. Shen T, Liu Y, Shang J, et al. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Gastroenterology. 2019;156(8):2230-2241.e11. doi: 10.1053/j.gastro.2019.02.002.
8. Ballotin VR, Bigarella LG, Brandão ABM, et al. Herb-induced liver injury: Systematic review and meta-analysis. World J Clin Cases. 2021;9(20):5490-5513. doi: 10.12998/wjcc.v9.i20.5490.
9. Navarro V. Liver Injury from Herbal and Dietary Supplements: An Introduction. Clin Liver Dis (Hoboken). 2019;14(2):43-44. doi: 10.1002/cld.870.
10. Kochetkov A.I., Akimova E. S., Ostroumova O. D. Pathogenetic mechanisms of drug-induced liver damage. Siberian Medical Review. 2020;(6):36-50. (In Russ.) doi: 10.20333/2500136-2020-6-36-50.@@ Кочетков А. И., Акимова Е. С., Остроумова О. Д. Патогенетические механизмы лекарственных повреждений печени. Сибирское медицинское обозрение. 2020;(6):36-50. doi: 10.20333/2500136-2020-6-36-50.
11. Liu Y, Li P, Wang F, et al.Comparison of diagnostic accuracy of 3 diagnostic criteria combined with refined pathological scoring system for drug-induced liver injury. Medicine (Baltimore). 2020;99(41): e22259. doi: 10.1097/MD.0000000000022259.
12. Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014;109(7):950-967. doi: 10.1038/ajg.2014.131.
13. Teschke R, Wolff A, Eickhoff A, Danan G. Is obesity rather than the dietary supplement used for weight reduction the cause of liver injury? JGH Open. 2018;2(4):152-157. doi: 10.1002/jgh3.12057.
14. Lua PL, Roslim NA, Ahmad A, et al.Complementary and Alternative Therapies for Weight Loss: A Narrative Review. J Evid Based Integr Med. 2021;26:2515690X211043738. doi: 10.1177/2515690X211043738.
Review
For citations:
Goma T.V., Kozlova N.M., Boldyreva K.S. The development of liver cirrhosis in a patient taking long-term weight loss supplements. Experimental and Clinical Gastroenterology. 2023;(8):176-183. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-216-8-176-183
Views:
696
Email this article 